Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-18

FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

FDA has approved Cranbury Pharmaceuticals' original application for a generic dextroamphetamine sulfate product. The approval covers its use for attention-defic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextroamphetamine sulfate (dextroamphetamine sulfate)

Snippet

ORIG AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)